Influenza A M2 Protein Inhibitor Drug Class List
✉ Email this page to a colleague
Drugs in Drug Class: Influenza A M2 Protein Inhibitor
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Impax Labs | RIMANTADINE HYDROCHLORIDE | rimantadine hydrochloride | TABLET;ORAL | 076132-001 | Aug 30, 2002 | RX | No | Yes | ⤷ Try for Free | ⤷ Try for Free | ⤷ Try for Free | ||||
| Supernus Pharms | OSMOLEX ER | amantadine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 209410-001 | Feb 16, 2018 | DISCN | Yes | No | 11,890,261 | ⤷ Try for Free | ⤷ Try for Free | ||||
| Supernus Pharms | OSMOLEX ER | amantadine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 209410-004 | Apr 22, 2020 | DISCN | Yes | No | 10,500,171 | ⤷ Try for Free | ⤷ Try for Free | ||||
| Supernus Pharms | OSMOLEX ER | amantadine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 209410-002 | Feb 16, 2018 | DISCN | Yes | No | 10,500,172 | ⤷ Try for Free | ⤷ Try for Free | ||||
| Supernus Pharms | OSMOLEX ER | amantadine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 209410-002 | Feb 16, 2018 | DISCN | Yes | No | 8,889,740 | ⤷ Try for Free | Y | ⤷ Try for Free | |||
| Supernus Pharms | OSMOLEX ER | amantadine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 209410-003 | Feb 16, 2018 | DISCN | Yes | No | 8,252,331 | ⤷ Try for Free | Y | ⤷ Try for Free | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Showing 1 to 6 of 6 entries
